Cellectis SA (CLLS)
1.76
-0.04
(-2.22%)
USD |
NASDAQ |
Nov 04, 16:00
1.77
+0.01
(+0.57%)
After-Hours: 20:00
Cellectis Market Cap: 177.17M for Nov. 4, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 01, 2024 | 180.17M |
| October 31, 2024 | 178.17M |
| October 30, 2024 | 182.17M |
| October 29, 2024 | 183.17M |
| October 28, 2024 | 193.18M |
| October 25, 2024 | 186.17M |
| October 24, 2024 | 190.18M |
| October 23, 2024 | 197.18M |
| October 22, 2024 | 180.17M |
| October 21, 2024 | 183.67M |
| October 18, 2024 | 190.18M |
| October 17, 2024 | 191.18M |
| October 16, 2024 | 190.18M |
| October 15, 2024 | 189.18M |
| October 14, 2024 | 195.18M |
| October 11, 2024 | 201.19M |
| October 10, 2024 | 200.19M |
| October 09, 2024 | 195.18M |
| October 08, 2024 | 196.18M |
| October 07, 2024 | 197.18M |
| October 04, 2024 | 189.58M |
| October 03, 2024 | 198.19M |
| October 02, 2024 | 196.18M |
| October 01, 2024 | 202.19M |
| September 30, 2024 | 212.20M |
| Date | Value |
|---|---|
| September 27, 2024 | 218.60M |
| September 26, 2024 | 219.20M |
| September 25, 2024 | 216.20M |
| September 24, 2024 | 221.21M |
| September 23, 2024 | 220.21M |
| September 20, 2024 | 225.91M |
| September 19, 2024 | 232.22M |
| September 18, 2024 | 228.21M |
| September 17, 2024 | 234.22M |
| September 16, 2024 | 230.22M |
| September 13, 2024 | 225.21M |
| September 12, 2024 | 240.22M |
| September 11, 2024 | 230.92M |
| September 10, 2024 | 222.21M |
| September 09, 2024 | 225.71M |
| September 06, 2024 | 224.21M |
| September 05, 2024 | 227.21M |
| September 04, 2024 | 230.22M |
| September 03, 2024 | 226.21M |
| August 30, 2024 | 240.22M |
| August 29, 2024 | 240.22M |
| August 28, 2024 | 237.22M |
| August 27, 2024 | 238.22M |
| August 26, 2024 | 240.22M |
| August 23, 2024 | 237.22M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
53.92M
Minimum
Oct 31 2023
1.422B
Maximum
Jan 19 2021
406.25M
Average
230.22M
Median
Jul 26 2024
Market Cap Benchmarks
| Genfit SA | 287.46M |
| DBV Technologies SA | 75.33M |
| Edap TMS SA | 100.92M |
| Adaptimmune Therapeutics PLC | 210.89M |
| Akari Therapeutics PLC | 28.93M |
Market Cap Related Metrics
| PS Ratio | 10.66 |
| Price to Book Value | 1.192 |
| Price to Free Cash Flow | 2.710 |
| Price | 1.76 |
| Earnings Yield | -81.36% |